Candice D Church

8PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 23, 2025
Circulating Neoantigen- and Viral Oncoprotein-Specific CD8+ T Cells Share a Transcriptional Signature.

Saumya Jani, Tomas Bencomo, Carolyn Shasha

|Sep 19, 2025
Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials.

Peter Y Ch'en, Yuzheng Zhang, Daniel S Hippe

|Aug 11, 2025
Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade.

Lisa Tachiki, Yasman Moshiri, Daniel S Hippe

|Oct 14, 2024
Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses.

Thomas Pulliam, Saumya Jani, Peter H Goff

|Oct 17, 2022
Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma.

Candice Church, Thomas Pulliam, Natalie Longino

|Oct 13, 2021
Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice.

Vandana Kalia, Yevgeniy Yuzefpolskiy, Adithya Vegaraju

Pageof 2

Frequent Collaborators

8 joint publications

Paul T Nghiem

5 joint publications

Thomas Pulliam

5 joint publications

David M Koelle

3 joint publications

Shailender Bhatia